latest news releases from the newsroom
Supernus Pharmaceuticals, Inc.
Supernus Announces Issuance of Fifth U.S. Patent Protecting Oxtellar XR(R)
ROCKVILLE, Md., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced the issuance on September 1, 2015 of a fifth patent (number 9,119,791) by the United States Patent and Trademark Office (USPTO) covering Oxtellar XR, its novel once-daily extended-release oxcarbazepine product. The patent provides protection for the product with expiration that is no earlier than 2027.
MarketAxess Holdings Inc.
MarketAxess Announces Monthly Volume Statistics for August 2015
NEW YORK, Sept. 2, 2015 (GLOBE NEWSWIRE) -- MarketAxess Holdings Inc. (Nasdaq:MKTX), the operator of a leading electronic trading platform for fixed-income securities, and the provider of market data and post-trade services for the global fixed-income markets, today announced total monthly trading volume for August 2015 of $75.5 billion, consisting of $43.7 billion in U.S. high-grade volume, $26.7 billion in other credit volume, and $5.1 billion in liquid products volume.
Fenix Parts, Inc.
Fenix Parts Announces Second Quarter 2015 Pro Forma Revenue
WESTCHESTER, Ill., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Fenix Parts, Inc. (Nasdaq:FENX), a leading recycler and reseller of original equipment manufacturer ("OEM") automotive products, today announced second quarter pro forma revenue for the three months ended June 30, 2015. On a pro forma basis, Fenix Parts generated second quarter revenue of approximately $27 million after intercompany eliminations. Fenix Parts' combined pro forma revenues for the quarter include the revenues of its eight Founding Companies, which were privately owned and operated until their acquisition on May 18, 2015. Due to professional fees, corporate expenses and other acquisition and IPO-related costs incurred during the period, the company expects to report a loss for the second quarter.